InVision Aktiengesellschaft

XTRA:IVX Rapport sur les actions

Capitalisation boursière : €13.2m

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

InVision Bilan de santé

Santé financière contrôle des critères 3/6

InVision possède un total de capitaux propres de €6.2M et une dette totale de €8.0M, ce qui porte son ratio d'endettement à 130.7%. Son actif total et son passif total sont €18.9M et de €12.8M.

Informations clés

130.7%

Ratio d'endettement

€8.04m

Dette

Ratio de couverture des intérêtsn/a
Argent liquide€7.10m
Fonds propres€6.15m
Total du passif€12.77m
Total des actifs€18.92m

Mises à jour récentes de la santé financière

Recent updates

Is InVision (ETR:IVX) Using Too Much Debt?

Oct 26
Is InVision (ETR:IVX) Using Too Much Debt?

InVision Aktiengesellschaft (ETR:IVX) Soars 35% But It's A Story Of Risk Vs Reward

Aug 31
InVision Aktiengesellschaft (ETR:IVX) Soars 35% But It's A Story Of Risk Vs Reward

Is InVision (ETR:IVX) Using Too Much Debt?

Jul 22
Is InVision (ETR:IVX) Using Too Much Debt?

Should You Think About Buying InVision Aktiengesellschaft (ETR:IVX) Now?

May 18
Should You Think About Buying InVision Aktiengesellschaft (ETR:IVX) Now?

InVision (ETR:IVX) Has Debt But No Earnings; Should You Worry?

Mar 16
InVision (ETR:IVX) Has Debt But No Earnings; Should You Worry?

Health Check: How Prudently Does InVision (ETR:IVX) Use Debt?

Jul 06
Health Check: How Prudently Does InVision (ETR:IVX) Use Debt?

Here's Why We Think InVision Aktiengesellschaft's (ETR:IVX) CEO Compensation Looks Fair for the time being

Sep 30
Here's Why We Think InVision Aktiengesellschaft's (ETR:IVX) CEO Compensation Looks Fair for the time being

Is InVision (ETR:IVX) Using Too Much Debt?

Sep 01
Is InVision (ETR:IVX) Using Too Much Debt?

It's Unlikely That InVision Aktiengesellschaft's (ETR:IVX) CEO Will See A Huge Pay Rise This Year

May 20
It's Unlikely That InVision Aktiengesellschaft's (ETR:IVX) CEO Will See A Huge Pay Rise This Year

InVision (ETR:IVX) Could Easily Take On More Debt

May 04
InVision (ETR:IVX) Could Easily Take On More Debt

InVision Aktiengesellschaft Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Mar 28
InVision Aktiengesellschaft Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Does InVision (ETR:IVX) Deserve A Spot On Your Watchlist?

Mar 15
Does InVision (ETR:IVX) Deserve A Spot On Your Watchlist?

Will InVision (ETR:IVX) Multiply In Value Going Forward?

Feb 25
Will InVision (ETR:IVX) Multiply In Value Going Forward?

InVision Aktiengesellschaft's (ETR:IVX) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Feb 08
InVision Aktiengesellschaft's (ETR:IVX) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Is InVision Aktiengesellschaft (ETR:IVX) Potentially Undervalued?

Jan 23
Is InVision Aktiengesellschaft (ETR:IVX) Potentially Undervalued?

These 4 Measures Indicate That InVision (ETR:IVX) Is Using Debt Safely

Jan 05
These 4 Measures Indicate That InVision (ETR:IVX) Is Using Debt Safely

InVision (ETR:IVX) Is Growing Earnings But Are They A Good Guide?

Dec 03
InVision (ETR:IVX) Is Growing Earnings But Are They A Good Guide?

What Do The Returns On Capital At InVision (ETR:IVX) Tell Us?

Nov 19
What Do The Returns On Capital At InVision (ETR:IVX) Tell Us?

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de IVX ( €9.2M ) dépassent ses passifs à court terme ( €3.8M ).

Passif à long terme: Les actifs à court terme de IVX ( €9.2M ) dépassent ses passifs à long terme ( €9.0M ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de IVX ( 15.2% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de IVX est passé de 7.2% à 130.7% au cours des 5 dernières années.

Couverture de la dette: Le flux de trésorerie opérationnel de IVX est négatif, par conséquent la dette n'est pas bien couverte.

Couverture des intérêts: Données insuffisantes pour déterminer si les paiements d'intérêts de IVX sur sa dette sont bien couverts par l'EBIT.


Bilan


Découvrir des entreprises saines